# Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery

> **NCT03120351** · NA · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 80 (actual)

## Conditions studied

- Perioperative Chest Pain

## Interventions

- **DRUG:** Lidoderm 5 % Topical Patch
- **DRUG:** Placebo patch

## Key facts

- **NCT ID:** NCT03120351
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03120351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03120351, "Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03120351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*